Chemoembolization and radioembolization for metastatic disease to the liver: Available data and future studies

Current Treatment Options in Oncology

Volumn 13, Issue 3, 2012, Pages 403-415

  Memon, Khairuddin ^a   Lewandowski, Robert J ^a   Riaz, Ahsun ^a   Salem, Riad ^a,b  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Chemoembolization; Drug eluting beads; Hepatic metastatic disease; Radioembolization

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IODINATED POPPYSEED OIL; IRINOTECAN; MACROSALB TC 99M; MITOMYCIN C; OXALIPLATIN; YTTRIUM 90;

ABDOMINAL PAIN; ALANINE AMINOTRANSFERASE TOXICITY; ALKALINE PHOSPHATASE TOXICITY; ARTICLE; ARTIFICIAL EMBOLISM; ASCITES; ASPARTATE AMINOTRANSFERASE TOXICITY; BILE DUCT INJURY; BILIRUBIN TOXICITY; BREAST CANCER; CANCER SIZE; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHEMORADIOTHERAPY; COLORECTAL CANCER; CONTINUOUS INFUSION; DRUG DELIVERY SYSTEM; DRUG ELUTING BEAD; DRUG INDUCED DISEASE; DRUG TOLERABILITY; FATIGUE; HUMAN; KARNOFSKY PERFORMANCE STATUS; KIDNEY CANCER; LIVER FUNCTION; LIVER METASTASIS; LIVER TOXICITY; METABOLIC DISORDER; NAUSEA; NEUROENDOCRINE TUMOR; NEUTROPENIA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PAIN; PATIENT SELECTION; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); POSITRON EMISSION TOMOGRAPHY; POSTEMBOLIZATION SYNDROME; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; RADIATION INDUCED LIVER DISEASE; RADIATION INJURY; RADIOEMBOLIZATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SKIN CANCER; TREATMENT INDICATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ANTINEOPLASTIC AGENTS; EMBOLIZATION, THERAPEUTIC; HUMANS; INJECTIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; RADIOISOTOPES;

EID: 84865690786     PISSN: 15272729     EISSN: 15346277     Source Type: Journal    
DOI: 10.1007/s11864-012-0200-x     Document Type: Article

References (70)

1. JA Norton 2005 Surgical treatment of neuroendocrine metastases Best Pract Res Clin Gastroenterol. 19 4 577 583 16183528 10.1016/j.bpg.2005.04.003
2. JS Tomlinson WR Jarnagin RP DeMatteo, et al. 2007 Actual 10-year survival after resection of colorectal liver metastases defines cure J Clin Oncol 25 29 4575 4580 17925551 10.1200/JCO.2007.11.0833
3. AR Sasson ER Sigurdson 2002 Surgical treatment of liver metastases Semin Oncol 29 2 107 118 11951208 10.1053/sonc.2002.31676
4. JA Ingold GB Reed HS Kaplan MA Bagshaw 1965 Radiation hepatitis Am J Roentgenol Radium Ther Nucl Med. 93 200 208 14243011 1:STN:280: DyaF2M%2FkslCnsA%3D%3D
5. C Breedis G Young 1954 The blood supply of neoplasms in the liver Am J Pathol 30 5 969 977 13197542 1:STN:280:DyaG2M%2FgvFWhtw%3D%3D
6. DM Liu R Salem JT Bui, et al. 2005 Angiographic considerations in patients undergoing liver-directed therapy J Vasc Interv Radiol 16 7 911 935 16002500 10.1097/01.RVI.0000164324.79242.B2
7. RJ Lewandowski KT Sato B Atassi, et al. 2007 Radioembolization with (90)y microspheres: angiographic and technical considerations Cardiovasc Intervent Radiol. 30 4 571 592 17516113 10.1007/s00270-007-9064-z
8. R Salem RJ Lewandowski KT Sato, et al. 2007 Technical aspects of radioembolization with 90Y microspheres Tech Vasc Interv Radiol 10 1 12 29 17980315 10.1053/j.tvir.2007.08.001
9. R Salem RJ Lewandowski L Kulik, et al. 2011 Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma Gastroenterology 140 2 497 507 e492 21044630 10.1053/j.gastro.2010.10.049 This is the first large study comparing matched cohorts of HCC patients treated with radioembolization and transarterial chemoembolization and suggests that patients treated with radioembolization demonstrate lower toxicity and longer time-to-progression.
10. R Salem RJ Lewandowski MF Mulcahy, et al. 2010 Radioembolization for hepatocellular carcinoma using yttrium-90 microspheres: a comprehensive report of long-term outcomes Gastroenterology 138 1 52 64 19766639 10.1053/j.gastro. 2009.09.006 1:CAS:528:DC%2BC3cXht1ajsLY%3D
11. RJ Lewandowski MF Mulcahy LM Kulik, et al. 2010 Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort Radiology 255 3 955 965 20501733 10.1148/radiol.10091473
12. JM Llovet MI Real X Montana, et al. 2002 Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 9319 1734 1739 12049862 10.1016/S0140-6736(02)08649-X
13. K Memon L Kulik RJ Lewandowski, et al. 2011 Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times Gastroenterology 141 2 526 35. e522 21664356 10.1053/j.gastro.2011.04.054 This study identifies radiologic response as a reliable predictor of survival outcomes in HCC patients treated with locoregional therapies and suggests adopting response as a surrogate of survival in clinical trials.
14. DM Coldwell KR Stokes WF Yakes 1994 Embolotherapy: agents, clinical applications, and techniques Radiographics 14 3 623 643 8066276 1:STN:280:DyaK2czksFWqsg%3D%3D quiz 645-6
15. MC Soulen 1994 Chemoembolization of hepatic malignancies Oncology (Williston Park). 8 4 77 84 1:STN:280:DyaK2c3ntFKktg%3D%3D discussion 84, 89-90 passim
16. B Solomon MC Soulen RA Baum ZJ Haskal RD Shlansky-Goldberg C Cope 1999 Chemoembolization of hepatocellular carcinoma with cisplatin, doxorubicin, mitomycin-C, ethiodol, and polyvinyl alcohol: prospective evaluation of response and survival in a U.S. population J Vasc Interv Radiol 10 6 793 798 10392950 10.1016/S1051-0443(99)70117-X 1:STN:280:DyaK1MzitVWhsw%3D%3D
17. M Albert MV Kiefer W Sun, et al. 2011 Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol Cancer 117 2 343 352 20830766 10.1002/cncr.25387 1:CAS:528:DC%2BC3MXhs1yrtro%3D This study analyzes survival and response after TACE in 121 patients with hepatic colorectal metastases and demonstrates survival advantage for those patients treated with TACE earlier in the course of treatment and in the era of biologic therapy with bevacizumab.
18. TJ Vogl T Gruber JO Balzer K Eichler R Hammerstingl S Zangos 2009 Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study Radiology 250 1 281 289 19092099 10.1148/radiol.2501080295 This study evaluated three chemoembolization protocols (mitomycin C alone, mitomycin C with gemcitabine, and mitomycin C with irinotecan) in 463 patients of hepatic metastases with colorectal cancer and found similar results among the three protocols.
19. C Tellez AB Benson 3rd MT Lyster, et al. 1998 Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature Cancer 82 7 1250 1259 9529016 10.1002/(SICI)1097-0142(19980401)82:7<1250::AID-CNCR7>3.0.CO;2-J 1:CAS:528:DyaK1cXitlWltbg%3D
20. Geschwind J, Hong K, Georgiades C. Utility of transcatheter arterial chemoembolization for liver dominant colorectal metastatic adenocarcinoma in the salvage setting. American Society of Clinical Oncology Gastrointestinal Cancers Symposium. San Francisco, CA, January 26-28, 2006.
21. E Liapi J-F Geschwind JA Vossen, et al. 2008 Functional MRI evaluation of tumor response in patients with neuroendocrine hepatic metastasis treated with transcatheter arterial chemoembolization Am J Roentgenol 190 1 67 73 10.2214/AJR.07.2550
22. Dong XD, Carr BI. Hepatic artery chemoembolization for the treatment of liver metastases from neuroendocrine tumors: a long-term follow-up in 123 patients. Med Oncol. 2011;28(Suppl 1):S286-90. Epub 2010 Nov 24. This is one of the few large studies investigating the role of chemoembolization in 123 patients with hepatic metastases from neuroendocrine tumors.
23. TJ Vogl T Gruber NN Naguib R Hammerstingl NE Nour-Eldin 2009 Liver metastases of neuroendocrine tumors: treatment with hepatic transarterial chemotherapy using two therapeutic protocols AJR Am J Roentgenol. 193 4 941 947 19770314 10.2214/AJR.08.1879
24. MF Giroux RA Baum MC Soulen 2004 Chemoembolization of liver metastasis from breast carcinoma J Vasc Interv Radiol 15 3 289 291 15028815 10.1097/01.RVI.0000116190.44877.04
25. M Buijs IR Kamel JA Vossen CS Georgiades K Hong JF Geschwind 2007 Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging J Vasc Interv Radiol 18 8 957 963 17675611 10.1016/j.jvir.2007.04.025
26. K Patel K Sullivan D Berd, et al. 2005 Chemoembolization of the hepatic artery with BCNU for metastatic uveal melanoma: results of a phase II study Melanoma Res. 15 4 297 304 16034309 10.1097/00008390-200508000-00011
27. GM Mavligit C Charnsangavej CH Carrasco YZ Patt RS Benjamin S Wallace 1988 Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cisplatin and polyvinyl sponge JAMA. 260 7 974 976 3398202 10.1001/jama.1988.03410070102037 1:STN:280:DyaL1c3os12kug%3D%3D
28. AY Bedikian SS Legha G Mavligit, et al. 1995 Treatment of uveal melanoma metastatic to the liver: a review of the M.D. Anderson Cancer Center experience and prognostic factors Cancer 76 9 1665 1670 8635073 10.1002/1097-0142(19951101) 76:9<1665::AID-CNCR2820760925>3.0.CO;2-J 1:CAS:528:DyaK28XjtFCi
29. T Vogl K Eichler S Zangos, et al. 2007 Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malignant melanoma: local tumor control and survival J Cancer Res Clin Oncol 133 3 177 184 17021903 10.1007/s00432-006-0155-z 1:CAS:528:DC%2BD2sXmt1Kksw%3D%3D
30. S Leyvraz V Spataro J Bauer, et al. 1997 Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy J Clin Oncol 15 7 2589 2595 9215829 1:CAS:528:DyaK2sXkslyms78%3D
31. J Xia Z Ren S Ye, et al. 2006 Study of severe and rare complications of transarterial chemoembolization (TACE) for liver cancer Eur J Radiol 59 3 407 412 16621394 10.1016/j.ejrad.2006.03.002
32. HK Kim YH Chung BC Song, et al. 2001 Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma J Clin Gastroenterol 32 5 423 427 11319315 10.1097/00004836-200105000-00013 1:STN:280:DC%2BD3M3jtFSksg%3D%3D
33. L Belli G Magistretti GP Puricelli G Damiani E Colombo GP Cornalba 1997 Arteritis following intra-arterial chemotherapy for liver tumors Eur Radiol 7 3 323 326 9087350 10.1007/s003300050159 1:STN:280:DyaK2s3ksVGrsw%3D%3D
34. K Hong CS Georgiades JF Geschwind 2006 Technology insight: Image-guided therapies for hepatocellular carcinoma-intra-arterial and ablative techniques Nat Clin Pract Oncol 3 6 315 324 16757969 10.1038/ncponc0512
35. R Martin J Joshi K Robbins, et al. 2011 Hepatic intra-arterial injection of drug-eluting bead, Irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic chemotherapy: results of multi-institutional study Ann Surg Oncol 18 1 192 198 20740319 10.1245/s10434-010-1288-5 This is one of few multi-institutional studies investigating the role of drug eluting beads loaded with irinotecan (DEBIRI) in patients with hepatic colorectal metastases and reports that DEBIRI is safe and effective for treatment of metastatic colorectal cancer refractory to multiple lines of systemic chemotherapy.
36. M Bower T Metzger K Robbins, et al. 2010 Surgical downstaging and neo-adjuvant therapy in metastatic colorectal carcinoma with irinotecan drug-eluting beads: a multi-institutional study HPB (Oxford). 12 1 31 36 10.1111/j.1477-2574.2009.00117.x
37. T de Baere F Deschamps C Teriitheau, et al. 2008 Transarterial chemoembolization of liver metastases from well-differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results J Vasc Interv Radiol 19 6 855 861 18503899 10.1016/j.jvir.2008.01.030
38. RC Martin K Robbins JF Fages, et al. 2012 Optimal outcomes for liver-dominant metastatic breast cancer with transarterial chemoembolization with drug-eluting beads loaded with doxorubicin Breast Cancer Res Treat. 132 2 753 763 22200868 10.1007/s10549-011-1926-z 1:CAS:528:DC%2BC38XktFOisLY%3D Epub 2011 Dec 27
39. RE Brown KM Gibler T Metzger, et al. 2011 Imaged guided transarterial chemoembolization with drug-eluting beads loaded with doxorubicin (DEBDOX) for hepatic metastases from melanoma: early outcomes from a multi-institutional registry Am Surg 77 1 93 98 21396314
40. TJ Vogl J Lammer R Lencioni, et al. 2011 Liver, gastrointestinal, and cardiac toxicity in intermediate hepatocellular carcinoma treated with PRECISION TACE with drug-eluting beads: results from the PRECISION V randomized trial AJR Am J Roentgenol. 197 4 W562 W570 21940527 10.2214/AJR.10.4379
41. JF Geschwind R Salem BI Carr, et al. 2004 Yttrium-90 microspheres for the treatment of hepatocellular carcinoma Gastroenterology 127 5 Suppl 1 S194 S205 15508085 10.1053/j.gastro.2004.09.034 1:CAS:528:DC%2BD2cXhtVGmtbzN
42. R Salem KG Thurston BI Carr JE Goin JF Geschwind 2002 Yttrium-90 microspheres: radiation therapy for unresectable liver cancer J Vasc Interv Radiol 13 9 Pt 2 S223 S229 12354840 10.1016/S1051-0443(07)61790-4
43. CY Wong R Salem S Raman VL Gates HJ Dworkin 2002 Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18 F]FDG PET: a comparison with CT or MRI Eur J Nucl Med Mol Imaging 29 6 815 820 12029557 10.1007/s00259-002-0787-4 1:CAS:528:DC%2BD38XlvVWms7s%3D
44. CY Wong R Salem F Qing, et al. 2004 Metabolic response after intraarterial 90Y-glass microsphere treatment for colorectal liver metastases: comparison of quantitative and visual analyses by 18 F-FDG PET J Nucl Med 45 11 1892 1897 15534060 1:CAS:528:DC%2BD2cXhtVKnur3E
45. JE Goin JE Dancey GA Hermann CJ Sickles CA Roberts JS MacDonald 2003 Treatment of unresectable metastatic colorectal carcinoma to the liver with intrahepatic Y-90 microspheres: a dose-ranging study World J of Nuc Med. 2 216 225
46. CY Wong F Qing M Savin, et al. 2005 reduction of metastatic load to liver after intra-arterial hepatic yttrium-90 radioembolization as evaluated by [18 F]fluorodeoxyglucose positron emission tomographic imaging J Vasc Interv Radiol 16 8 1101 1106 16105922 10.1097/01.RVI.0000168104.32849.07
47. MF Mulcahy RJ Lewandowski SM Ibrahim, et al. 2009 Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres Cancer 115 9 1849 1858 19267416 10.1002/cncr.24224
48. KT Sato RJ Lewandowski MF Mulcahy, et al. 2008 Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres-safety, efficacy, and survival Radiology 247 2 507 515 18349311 10.1148/radiol.2472062029
49. B Gray G Van Hazel M Hope, et al. 2001 Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer Ann Oncol 12 12 1711 1720 11843249 10.1023/A:1013569329846 1:STN:280:DC%2BD387htF2gsw%3D%3D
50. AS Kennedy D Coldwell C Nutting, et al. 2006 Resin (90)Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience Int J Radiat Oncol Biol Phys 65 2 412 425 16690429 10.1016/j.ijrobp.2005.12.051 1:CAS:528:DC%2BD28XksVCktLY%3D
51. TF Jakobs RT Hoffmann K Dehm, et al. 2008 Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases J Vasc Interv Radiol 19 8 1187 1195 18656012 10.1016/j.jvir.2008.05.013
52. RA Sharma GA Van Hazel B Morgan, et al. 2007 Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy J Clin Oncol 25 9 1099 1106 17369573 10.1200/JCO.2006.08.7916 1:CAS:528:DC%2BD2sXksVyrs7o%3D
53. A Hendlisz M Van den Eynde M Peeters, et al. 2010 Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy J Clin Oncol 28 23 3687 3694 20567019 10.1200/JCO.2010.28.5643 1:CAS:528:DC%2BC3cXhtFahs7%2FK This study compared intravenous fluorouracil infusion alone and its combination with radioembolization in a phase III trial in patients with hepatic colorectal metastases. The results demonstrated significant improvement in time to tumor progression and time to liver progression in patients treated with the combination.
54. Coldwell D, Nutting C, Kennedy AK. Treatment of hepatic metastases from breast cancer with yttrium-90 SIR-Spheres radioembolization. Paper presented at: Society of Interventional Radiology Annual Meeting; March 31-April 5, 2005; New Orleans, LA.
55. 90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival J Vasc Interv Radiol 18 5 621 628 17494843 10.1016/j.jvir.2007.02.019
56. Coldwell D, Nutting C, Kennedy AK. Use of yttrium-90 SirSpheres to treat metastatic unresectable neuroendorcine tumors to the liver. Paper presented at: World Congress of Gastrointestinal Cancer; June 27-30, 2005; Barcelona, Spain.
57. 90Y radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience Ann Surg 247 6 1029 1035 18520231 10.1097/SLA.0b013e3181728a45
58. Memon K, Lewandowski RJ, Mulcahy MF, et al. Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes. Int J Radiat Oncol Biol Phys. 2012;83(3):887-94. Epub 2011 Dec 2. This study analyzed the role of radioembolization in 40 patients with unresectable hepatic neuroendocrine metastases with imaging-confirmed progressive disease refractory to systemic therapy and demonstrated encouraging outcomes in terms of toxicity, response, and survival.
59. CF Gonsalves DJ Eschelman KL Sullivan PR Anne L Doyle T Sato 2011 Radioembolization as salvage therapy for hepatic metastasis of uveal melanoma: a single-institution experience AJR Am J Roentgenol. 196 2 468 473 21257902 10.2214/AJR.10.4881 This is one of the very few studies analyzing the role of radioembolization in patients with hepatic metastases from uveal melanoma.
60. MHK Abdelmaksoud JD Louie GL Hwang N Kothary DR Minor DY Sze 2012 Yttrium-90 radioembolization of renal cell carcinoma metastatic to the liver J Vasc Interv Radiol 23 3 323 30.e321 22277275 10.1016/j.jvir.2011.11.007
61. R Salem RJ Lewandowski B Atassi, et al. 2005 Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival J Vasc Interv Radiol 16 12 1627 1639 16371529 10.1097/01.RVI.0000184594.01661.81
62. R Murthy H Xiong R Nunez, et al. 2005 Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results J Vasc Interv Radiol 16 7 937 945 16002501 10.1097/01.RVI.0000161142.12822.66
63. B Sangro B Gil-Alzugaray J Rodriguez, et al. 2008 Liver disease induced by radioembolization of liver tumors: description and possible risk factors Cancer 112 7 1538 1546 18260156 10.1002/cncr.23339
64. JY Young TK Rhee B Atassi, et al. 2007 Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma J Vasc Interv Radiol 18 11 1375 1382 18003987 10.1016/j.jvir.2007.07.016
65. TF Jakobs S Saleem B Atassi, et al. 2008 Fibrosis, portal hypertension, and hepatic volume changes induced by intra-arterial radiotherapy with (90)yttrium microspheres Dig Dis Sci 53 9 2556 2563 18231857 10.1007/s10620-007-0148-z 1:STN:280:DC%2BD1crivVWquw%3D%3D
66. TK Rhee NK Naik J Deng, et al. 2008 Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging J Vasc Interv Radiol 19 8 1180 1186 18656011 10.1016/j.jvir.2008.05.002
67. TheraSphere Yttrium-90 microspheres package insert, MDS Nordion, Kanata, Canada, 2004.
68. R Murthy DB Brown R Salem, et al. 2007 Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy J Vasc Interv Radiol 18 4 553 561 17446547 10.1016/j.jvir.2007.02.002 quiz 562
69. C Carretero M Munoz-Navas M Betes, et al. 2007 Gastroduodenal injury after radioembolization of hepatic tumors Am J Gastroenterol 102 6 1216 1220 17355414 10.1111/j.1572-0241.2007.01172.x Epub 2007 Mar 13
70. R Murthy C Eng S Krishnan, et al. 2007 Hepatic yttrium-90 radioembolotherapy in metastatic colorectal cancer treated with cetuximab or bevacizumab J Vasc Interv Radiol 18 12 1588 1591 18057297 10.1016/j.jvir.2007. 08.015